Diseases & Disorders
(G20)
THERAPIES FOR INHERITED NEUROPATHIES INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$233K
Total Revenue
$119K
Total Expenses
$424K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.4%
Fundraising Efficiency
0.0%
Operating Reserve
42.68x
Liability-to-Asset
0.0%
Revenue Diversification
116.7%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $233K | $119K | $424K | 96.4% | 0 |
| 2022 | $277K | $370K | N/A | — | 0 |
| 2021 | $407K | $222K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.